Speaker illustration

Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)

Member of:

European Society of Cardiology

Dr. Schwartz is Professor of Medicine at the University of Colorado School of Medicine and Chief, Cardiology Section, Rocky Mountain Regional VA Medical Center in Aurora, Colorado, USA. His basic and clinical research focuses on lipid and metabolic interventions in coronary heart disease. He has participated in the design and leadership of large clinical trials in this area. Dr. Schwartz received his MD and PhD degrees from Duke University and fellowship training in Cardiovascular Disease at the University of California, San Francisco (UCSF), where he also served on the faculty.

Applying ODYSSEY Outcomes in your clinical practice - Who are the most appropriate patients for PCSK9 inhibitor treatment?

Event: ESC Congress 2019

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium - Experts on the Spot


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb